HPWM
IBB icon

High Point Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

High Point Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Hold
75
– – 0.01% 204
2026
Q1 		$12.7K Sell
75
-64
-46% -$10.9K 0.01% 204
2025
Q4 		$23.5K Buy
+139
New +$22.6K 0.02% 186

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

High Point Wealth Management's IBB Position: Q2 2026 in Review

High Point Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 75 shares worth $14.3K. The position accounts for 0.01% of the portfolio, ranked #204.

High Point Wealth Management first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.5K in Q4 2025. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • High Point Wealth Management held 75 shares of iShares Biotechnology ETF worth $14.3K as of Q2 2026.
  • High Point Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of High Point Wealth Management's portfolio in Q2 2026, its #204 holding.
  • High Point Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • High Point Wealth Management's iShares Biotechnology ETF position peaked at $23.5K in Q4 2025.
  • 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on High Point Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.